Investment
Features
FeesSafety
Academy
More
Pluang+

Omega Pacific launches 5,000m drill program at Williams Gold Project in BC's Toodoggone District

Market News
06 Oct 2026
Newsfile Corp
View Source
Bullish
Omega Pacific launches 5,000m drill program at Williams Gold Project in BC's Toodoggone District

Omega Pacific Resources Ltd. has initiated a 5,000-metre drilling program at its Williams Gold Project in British Columbia's Toodoggone District following promising 2024 gold discoveries. The project targets gold and copper-gold porphyry deposits amid rising investment and central bank demand for gold. This exploration effort aims to build on previous high-grade drill results and capitalize on renewed interest in gold exploration. Omega Pacific continues to evaluate other mineral assets domestically and internationally.

Omega Pacific Resources' gold exploration update is presented with Pluang's Basic Materials sector data as of Oct 07, 2026 00:21 WIB. For readers following this sector, 30 of 38 priced US stocks rose while 8 fell. Notable movers include Nutrien Ltd (NTR) at USD 71.27 with a 1-day change of +1.44%, ArcelorMittal SA (MT) at USD 65.62 with +1.37%, and Standard Lithium Ltd (SLI) at USD 1.70 with -1.45%. The most notable figure is the 90% sell order activity on SLI on Pluang.

More News

Bank OZK to report Q3 2026 earnings on Oct 20 amid Citigroup's Sell rating at $45.59

Bank OZK to report Q3 2026 earnings on Oct 20 amid Citigroup's Sell rating at $45.59

Bank OZK is scheduled to release its Q3 2026 earnings after market close on October 20, providing investors with updated financial results to compare against Citigroup's current Sell rating. The bank's latest balance sheet shows $41.70 billion in tot...

Company Fundamentals
Neutral
45 minutes ago
Scotiabank raises Pfizer price target to $33, signaling 20.9% potential gain.

Scotiabank raises Pfizer price target to $33, signaling 20.9% potential gain.

Scotiabank has increased its price target for Pfizer stock from $30.00 to $33.00, suggesting a potential upside of 20.9% from the current trading price of $27.31. Pfizer, a major pharmaceutical company, holds a strong buy rating with a Zacks Rank of ...

Analyst Insights
Bullish
1 hour ago
Citigroup raises AstraZeneca price target after strong clinical trial results

Citigroup raises AstraZeneca price target after strong clinical trial results

Citigroup has raised its price target for AstraZeneca to £186.00 from £178.00, maintaining a Buy rating following successful Phase 3 clinical trials. The increase reflects higher peak sales forecasts for drugs tozorakimab and SERENA-6, offsetting the...

Analyst Insights
Bullish
1 hour ago
Devon Energy shares seen rising 40% as analyst sets $67 price target amid asset sale pressures.

Devon Energy shares seen rising 40% as analyst sets $67 price target amid asset sale pressures.

An analyst from BMO Capital set a $67 price target for Devon Energy, suggesting a 40% upside from its current share price of around $48. The oil and gas producer has consistently beaten earnings estimates recently, showing strong financial health. Ho...

Analyst Insights
Bullish
2 hours ago
$10,000 in Marvell stock 10 years ago is now worth about $206,000, needing 35% annual growth to repeat.

$10,000 in Marvell stock 10 years ago is now worth about $206,000, needing 35% annual growth to repeat.

An investment of $10,000 in Marvell stock a decade ago has grown to approximately $206,000 today. Achieving the same growth again would require an annual earnings increase of 35%. This highlights Marvell's strong past performance and the challenge of...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App